ASP Isotopes Inc. (NASDAQ:ASPI) Sees Significant Growth in Short Interest

ASP Isotopes Inc. (NASDAQ:ASPI) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 6,770,000 shares, an increase of 13.8% from the December 15th total of 5,950,000 shares. Currently, 14.6% of the company’s stock are sold short. Based on an average daily volume of 5,090,000 shares, the days-to-cover ratio is currently 1.3 days.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of ASPI. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new position in ASP Isotopes during the 3rd quarter worth approximately $6,249,000. Telemark Asset Management LLC bought a new stake in shares of ASP Isotopes in the 3rd quarter worth approximately $4,726,000. Philadelphia Financial Management of San Francisco LLC lifted its holdings in shares of ASP Isotopes by 158.3% in the 3rd quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock worth $2,757,000 after purchasing an additional 607,893 shares during the last quarter. Marshall Wace LLP lifted its holdings in shares of ASP Isotopes by 389.6% in the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock worth $1,668,000 after purchasing an additional 433,734 shares during the last quarter. Finally, GSA Capital Partners LLP lifted its holdings in shares of ASP Isotopes by 96.0% in the 3rd quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock worth $2,143,000 after purchasing an additional 377,721 shares during the last quarter. Institutional investors own 16.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on ASPI shares. Canaccord Genuity Group started coverage on ASP Isotopes in a research note on Friday, October 4th. They set a “buy” rating and a $4.50 price objective for the company. Canaccord Genuity Group restated a “buy” rating and set a $4.50 price objective on shares of ASP Isotopes in a research note on Friday, October 18th.

ASP Isotopes Trading Up 10.1 %

NASDAQ:ASPI opened at $5.66 on Friday. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80. The business’s 50 day moving average is $5.51 and its two-hundred day moving average is $4.08. ASP Isotopes has a 52 week low of $1.86 and a 52 week high of $9.33. The company has a market cap of $404.07 million, a PE ratio of -9.28 and a beta of 3.48.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.